AAAAAA
Results: 1-25/52
Authors:
Wiesner, RH
McDiarmid, SV
Kamath, PS
Edwards, EB
Malinchoc, M
Kremers, WK
Krom, RAF
Kim, WR
Citation: Rh. Wiesner et al., MELD and PELD: Application of survival models to liver allocation, LIVER TRANS, 7(7), 2001, pp. 567-580
Authors:
Charlton, M
Kasparova, P
Weston, S
Lindor, K
Maor-Kendler, Y
Wiesner, RH
Rosen, CB
Batts, KP
Citation: M. Charlton et al., Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease, LIVER TRANS, 7(7), 2001, pp. 608-614
Authors:
Gonzalez-Koch, A
Czaja, AJ
Carpenter, HA
Roberts, SK
Charlton, MR
Porayko, MK
Rosen, CB
Wiesner, RH
Citation: A. Gonzalez-koch et al., Recurrent autoimmune hepatitis after orthotopic liver transplantation, LIVER TRANS, 7(4), 2001, pp. 302-310
Authors:
Arslan, M
Wiesner, RH
Sievers, C
Egan, K
Zein, NN
Citation: M. Arslan et al., Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease, LIVER TRANS, 7(4), 2001, pp. 314-320
Authors:
Wiesner, RH
Menon, KVN
Citation: Rh. Wiesner et Kvn. Menon, Late hepatic allograft dysfunction, LIVER TRANS, 7(11), 2001, pp. S60-S73
Authors:
Wiesner, RH
Krom, RAF
Citation: Rh. Wiesner et Raf. Krom, Beyond 2000, LIVER TRANS, 7(1), 2001, pp. 1-1
Authors:
Patel, R
Allen, SL
Manahan, JM
Wright, AJ
Krom, RAF
Wiesner, RH
Persing, DH
Cockerill, FR
Thompson, RL
Citation: R. Patel et al., Natural history of vancomycin-resistant enterococcal colonization in liverand kidney transplant recipients, LIVER TRANS, 7(1), 2001, pp. 27-31
Authors:
Wiesner, RH
Citation: Rh. Wiesner, Liver transplantation for primary sclerosing cholangitis: timing, outcome,impact of inflammatory bowel disease and recurrence of disease, BEST PR RES, 15(4), 2001, pp. 667-680
Authors:
Kim, WR
Kremers, W
Kamath, PS
Wiesner, RH
Malinchoc, M
Therneau, TM
Dickson, ER
Citation: Wr. Kim et al., To MELD or not to MELD? Reply, HEPATOLOGY, 34(1), 2001, pp. 215-216
Authors:
Kamath, PS
Wiesner, RH
Malinchoc, M
Kremers, W
Therneau, TM
Kosberg, CL
D'Amico, G
Dickson, ER
Kim, WR
Citation: Ps. Kamath et al., A model to predict survival in patients with end-stage liver disease, HEPATOLOGY, 33(2), 2001, pp. 464-470
Authors:
Arslan, M
Wiesner, RH
Poterucha, JJ
Zein, NN
Citation: M. Arslan et al., Safety and efficacy of hepatitis A vaccination in liver transplantation recipients, TRANSPLANT, 72(2), 2001, pp. 272-276
Authors:
Halling, VW
Maine, GT
Groettum, CM
Wilson, JA
Spesard, J
Brojanac, S
Combs, B
Wachta, D
Holas, C
Wilson, T
Wang, D
Tomazic-Allen, S
Lazzarotto, T
Landini, MP
Jevremovic-Simovic, S
Wiesner, RH
Paya, CV
Smith, TF
Citation: Vw. Halling et al., Clinical evaluation of a new recombinant antigen-based cytomegalovirus immunoglobulin M immunoassay in liver transplant recipients, TRANSPLANT, 71(3), 2001, pp. 395-397
Authors:
Talwalkar, JA
Seaberg, E
Kim, WR
Wiesner, RH
Citation: Ja. Talwalkar et al., Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score, LIVER TRANS, 6(6), 2000, pp. 753-758
Authors:
Wiesner, RH
Krom, RAF
Citation: Rh. Wiesner et Raf. Krom, Good news for our journal Liver Transplantation, LIVER TRANS, 6(4), 2000, pp. 395-395
Authors:
Krowka, MJ
Plevak, DJ
Findlay, JY
Rosen, CB
Wiesner, RH
Krom, RAF
Citation: Mj. Krowka et al., Pulmonary hemodynamics and perioperative cardiopulmonary-related mortalityin patients with portopulmonary hypertension undergoing liver transplantation, LIVER TRANS, 6(4), 2000, pp. 443-450
Authors:
Kim, WR
Krowka, MJ
Plevak, DJ
Lee, J
Rettke, SR
Frantz, RP
Wiesner, RH
Citation: Wr. Kim et al., Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates, LIVER TRANS, 6(4), 2000, pp. 453-458
Authors:
Kim, WR
Wiesner, RH
Poterucha, JJ
Therneau, TM
Benson, JT
Krom, RAF
Dickson, ER
Citation: Wr. Kim et al., Adaptation of the Mayo primary biliary cirrhosis natural history model forapplication in liver transplant candidates, LIVER TRANS, 6(4), 2000, pp. 489-494
Authors:
Arslan, M
Wiesner, RH
Poterucha, JJ
Gross, JB
Zein, NN
Citation: M. Arslan et al., Hepatitis A antibodies in liver transplant recipients: Evidence for loss of immunity posttransplantation, LIVER TRANS, 6(2), 2000, pp. 191-195
Authors:
Wiesner, RH
Krom, RAF
Citation: Rh. Wiesner et Raf. Krom, The changing of the guard: A new editorial team, LIVER TRANS, 6(1), 2000, pp. 1-2
Authors:
Nyberg, SL
Hibbs, JR
Hardin, JA
Germer, JJ
Platt, JL
Paya, CV
Wiesner, RH
Citation: Sl. Nyberg et al., Influence of human fulminant hepatic failure sera on endogenous retroviralexpression in pig hepatocytes, LIVER TRANS, 6(1), 2000, pp. 76-84
Authors:
Taler, SJ
Textor, SC
Canzanello, VJ
Schwartz, L
Porayko, MK
Wiesner, RH
Krom, RAF
Citation: Sj. Taler et al., Hypertension after liver transplantation - A predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulations, AM J HYPERT, 13(3), 2000, pp. 231-239
Authors:
Guerrero, RB
Batts, KP
Burgart, LJ
Barrett, SL
Germer, JJ
Poterucha, JJ
Wiesner, RH
Charlton, MR
Persing, DH
Citation: Rb. Guerrero et al., Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: A molecular and histologic study, MOD PATHOL, 13(3), 2000, pp. 229-237
Authors:
Gaweco, AS
Wiesner, RH
Porayko, M
Rustgi, VK
Yong, S
Hamdani, R
Harig, J
Chejfec, G
McClatchey, KD
Van Thiel, DH
Citation: As. Gaweco et al., Intragraft localization of activated nuclear factor kappa B in recurrent hepatitis C virus disease following liver transplantation, HEPATOLOGY, 31(5), 2000, pp. 1183-1191
Authors:
Zein, NN
Perez, RG
Wiesner, RH
Citation: Nn. Zein et al., Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation, HEPATOLOGY, 31(3), 2000, pp. 808-809
Authors:
Zein, NN
Abdulkarim, AS
Wiesner, RH
Egan, KS
Persing, DH
Citation: Nn. Zein et al., Prevalence of diabetes mellitus in patients with end-stage liver cirrhosisdue to hepatitis C, alcohol, or cholestatic disease, J HEPATOL, 32(2), 2000, pp. 209-217